Target intelligence / Profile preview

Mycobacterium tuberculosis coenzyme A biosynthesis enzymes (Mtb CoA biosynthesis enzymes)

Target
Mtb CoA biosynthesis enzymes
Molecular classification
Enzyme
01

Overview

Mycobacterium tuberculosis coenzyme A biosynthesis enzymes constitute a vital metabolic pathway essential for the survival, persistence, and virulence of the tuberculosis-causing bacterium [1]. Coenzyme A (CoA) is a universal cofactor required for approximately 9% of all cellular enzymatic reactions, including the tricarboxylic acid cycle, fatty acid metabolism, and the synthesis of complex cell wall lipids like mycolic acids [1, 3]. In M. tuberculosis, this pathway involves several key enzymes: pantothenate kinase (PanK/CoaA), the bifunctional phosphopantothenoylcysteine synthetase/decarboxylase (CoaBC), phosphopantetheine adenylyltransferase (CoaD), and dephospho-CoA kinase (CoaE) [2, 3]. These enzymes are considered high-value therapeutic targets because they are essential for the pathogen and often exhibit significant structural differences from their human orthologs, allowing for selective inhibition [1, 4]. Inhibition of these enzymes leads to the depletion of intracellular CoA pools, which catastrophically disrupts energy production and cell envelope integrity [3, 4]. The first-line antitubercular drug pyrazinamide, via its active form pyrazinoic acid, has been shown to target PanD, an enzyme in the pantothenate/CoA biosynthetic route, thereby validating the pathway's clinical relevance [1, 4]. Recent drug discovery efforts have identified potent small-molecule inhibitors, such as compound 1f targeting CoaB, which demonstrate whole-cell activity against M. tuberculosis [3]. Despite the potential, challenges remain regarding the ability of the bacteria to scavenge host-derived intermediates and the development of resistance through metabolic bypass [1, 3].

Other names
Coenzyme A biosynthetic pathway enzymesMtb CoA enzymesPantothenate and coenzyme A biosynthesis pathwayPanKCoaBCCoaDCoaECoA biosynthetic pathway
02

Mechanism of action

Inhibition of coenzyme A biosynthesis leading to depletion of essential metabolic cofactors and disruption of lipid and energy metabolism.

03

Biological functions

Cell proliferationCell deathOther
04

Disease associations

Infection
05

Safety considerations

Target selectivity over human orthologsPotential for metabolic bypass via host-derived intermediatesDevelopment of drug resistance
06

Interacting drugs

Pyrazinamide

4 more in the full profile.

07

Biomarkers

Intracellular coenzyme A levels4-phosphopantothenate levelsSputum culture conversion

Beyond the preview

Go deeper on Mycobacterium tuberculosis coenzyme A biosynthesis enzymes (Mtb CoA biosynthesis enzymes).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis coenzyme A biosynthesis enzymes (Mtb CoA biosynthesis enzymes).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call